Ph+ ALL is a primarily pediatric cancer characterized by the presence of the t(9;22) (q34.1; q11.2) translocation and expression of the fusion oncogene BCR-ABL, akin to Ph+ CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.